• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Transcriptomic Analysis Identifies Candidate Hub Genes and Immune Signatures in Insomnia

by
November 7, 2026
in Health
Reading Time: 7 mins read
0
Transcriptomic Analysis Identifies Candidate Hub Genes and Immune Signatures in Insomnia

Transcriptomic Analysis Identifies Candidate Hub Genes and Immune Signatures in Insomnia

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A multi-layer bioinformatic investigation analyzing peripheral blood mononuclear cell microarrays has identified three candidate hub genes and prioritized oxidative stress pathways in patients with chronic insomnia. Published in the Egyptian Journal of Medical Human Genetics, the discovery-stage study evaluated peripheral blood gene expression profiles from seventeen patients diagnosed with chronic insomnia and twenty-five healthy control participants aged sixty to eighty years. Researchers deployed an integrated computational pipeline spanning seven analytical layers, including pathway-level enrichment scoring, weighted gene co-expression network analysis, machine-learning feature prioritization, cross-cohort transcriptomic comparisons across acute sleep-loss paradigms, immune-cell deconvolution, summary-data-based Mendelian randomization, and drug-gene interaction queries. The primary screening highlighted serine palmitoyltransferase long chain base subunit 1, prostaglandin E synthase 3, and human leukocyte antigen G as consensus core candidate hub genes associated with insomnia-related immune and stress dysregulation.

Chronic insomnia represents a highly prevalent sleep disorder affecting approximately ten to fifteen percent of the global adult population, with reported prevalence rates climbing to between thirty and forty-eight percent among older demographic groups. Beyond compromising cognitive functioning and day-to-day quality of life, prolonged sleep disturbance is epidemiologically linked to heightened clinical risks of cardiovascular disease, major depression, and metabolic syndrome. While clinical literature increasingly supports a bidirectional relationship linking disturbed sleep patterns to altered peripheral immune function, the underlying molecular perturbations, candidate genomic markers, and the precise balance between germline genetic influences and state-dependent regulatory mechanisms have remained poorly understood. Prior research has frequently examined acute sleep deprivation or isolated circulating inflammatory markers, leaving a notable gap in comprehensive transcriptome-wide profiling of immune networks in clinically defined chronic insomnia.

To investigate these immune transcriptional dynamics, the researchers accessed the publicly available GSE208668 dataset from the NCBI Gene Expression Omnibus, which was originally generated using the Illumina HumanHT-12 V4.0 Expression BeadChip platform. The dataset comprised 14,539 expressed genes profiled across forty-two peripheral blood mononuclear cell samples from individuals diagnosed under the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Within this dataset, the seventeen insomnia samples were drawn from the Behavioral Treatment of Insomnia in Aging clinical trial cohort, whereas the twenty-five healthy control samples originated from the Sleep Health and Aging Research field study. Although all samples were processed within a single experimental batch at the UCLA Neuroscience Genomics Core Laboratory to minimize technical batch artifacts, unsupervised principal component analysis revealed distinct clustering patterns corresponding to cohort origin, explaining 88.44 percent of the variance on the first principal component and 5.06 percent on the second, precluding the complete separation of cohort-specific differences from true insomnia-associated pathology.

To quantify the relative biological activation across distinct immune pathways, the team performed gene set variation analysis using five hypothesis-driven gene sets curated from prior scientific literature. These predefined sets encompassed canonical nuclear factor kappa B signaling consisting of twenty-five genes, glucocorticoid response containing fifteen represented genes out of eighteen defined, interferon-stimulated genes comprising twelve genes, the inflammasome pathway with ten represented genes out of eleven defined, and oxidative stress comprising eight genes regulated by Nrf2. Seventy of the seventy-four curated pathway genes were successfully matched within the normalized microarray expression matrix. Using Cohen’s d effect-size calculations alongside Wilcoxon rank-sum testing, the authors quantitatively ranked pathway activation. Oxidative stress demonstrated the largest observed effect-size estimate among all five evaluated pathways, yielding a Cohen’s d of 0.856, although the between-group statistical comparison did not achieve conventional significance with a p-value of 0.057. Nuclear factor kappa B signaling followed with an effect size of 0.489 and a p-value of 0.153, while glucocorticoid response yielded an effect size of 0.415 and a p-value of 0.193. In contrast, interferon-stimulated genes showed a mild negative effect size of negative 0.253, and the inflammasome pathway demonstrated a near-zero effect size of negative 0.002.

Global co-expression patterns were subsequently analyzed using weighted gene co-expression network analysis focused on the top fifteen percent most variable genes, encompassing 2,181 transcripts. Applying a soft-thresholding power of six, where the scale-free topology fit index reached 0.41 and connectivity stabilized, the network partitioned into a single dominant turquoise co-expression module containing 2,178 genes, accompanied by a residual grey module of three unassigned genes. Module eigengene correlation analysis demonstrated that the turquoise module was significantly negatively correlated with both chronic insomnia status, showing a correlation coefficient of negative 0.44 and a p-value of 0.003, and Beck Depression Inventory scores, with a correlation of negative 0.40 and a p-value of 0.008. In contrast, the module showed no significant correlation with chronological age or body mass index. Filtering within this module using dual thresholds of absolute module membership greater than 0.7 and absolute gene significance greater than 0.15 yielded 2,120 hub genes for subsequent machine-learning prioritization.

To refine this large candidate set and minimize single-model algorithmic bias under small-sample constraints, three distinct machine-learning feature-selection methods were executed in parallel: least absolute shrinkage and selection operator logistic regression, Random Forest, and the Boruta wrapper algorithm. At an optimal regularization parameter of lambda min equal to 0.00455, LASSO selected three non-zero coefficient genes: SPTLC1, PTGES3, and HLA-G. Random Forest, configured with five hundred trees and exhibiting an out-of-bag error rate of zero percent, prioritized the top thirty genes by mean decrease in Gini impurity. Boruta confirmed a subset of significant attributes after five hundred runs. Combining these outputs, SPTLC1 emerged as the sole Tier 1 gene unanimously selected across all three algorithms, while PTGES3 and HLA-G were identified as Tier 2 candidates selected jointly by LASSO and Boruta. An internal logistic regression classifier trained on these three core hub genes achieved complete group separation under leave-one-out cross-validation, with an area under the receiver operating characteristic curve, sensitivity, specificity, and F1-score of 1.000. Bootstrap resampling across one thousand iterations similarly maintained an apparent area under the curve of 1.000, which the authors explicitly noted reflects internal data separability rather than verified clinical diagnostic accuracy or protection against potential model overfitting.

All three core consensus genes demonstrated substantial individual upregulation within the discovery cohort, with log twofold changes of positive 2.04 for SPTLC1, positive 2.44 for PTGES3, and positive 2.45 for HLA-G, while also exhibiting negative module membership values within the overall downregulated turquoise network. Biologically, SPTLC1 encodes the long-chain subunit 1 of serine palmitoyltransferase, serving as the rate-limiting enzyme in de novo ceramide biosynthesis, a metabolic cascade linked to neuroinflammation, cellular apoptosis, and depressive symptoms. PTGES3, identical to the molecular co-chaperone p23, participates directly in stabilizing client proteins of the heat shock protein 90 and glucocorticoid receptor complex, aligning with observed trends in glucocorticoid response signaling and insomnia-depression comorbidity. HLA-G encodes a non-classical major histocompatibility complex class I molecule that binds inhibitory receptors on natural killer and T cells to promote immune tolerance, highlighting a potential immunogenetic regulatory component in chronic sleep disturbance.

To contextualize whether these transcriptomic alterations reflect general sleep disruption or persistent pathology, the investigators compared the nine prioritized candidate genes against three public acute sleep-loss datasets: GSE39445, evaluating one-week sleep restriction; GSE98566, assessing sixty-two hours of total sleep deprivation; and GSE56931, testing thirty-eight hours of sustained wakefulness. Differential expression analyses conducted using linear models revealed that the robust upregulation observed in the chronic insomnia cohort, where log fold changes spanned from positive 0.94 to positive 2.81, was not recapitulated under acute conditions. In the acute cohorts, candidate gene expression remained largely unchanged or directionally discordant, with log fold changes fluctuating within a narrow range between negative 0.22 and positive 0.10. Specifically, HLA-G exhibited slight downregulation across all three acute sleep-loss cohorts, in direct contrast to its marked upregulation in chronic insomnia. The investigators stressed that this discordance represents a contextual comparison across differing experimental paradigms and platforms rather than definitive proof of chronic-insomnia specificity or external validation.

Cellular composition was estimated using CIBERSORTx deconvolution based on the LM22 leukocyte reference signature matrix across one hundred permutations. In the primary quality-controlled analysis, which retained thirty-four samples with deconvolution p-values below 0.05, including all seventeen insomnia cases and seventeen controls, five cell subsets demonstrated statistically significant differences following Benjamini-Hochberg correction. The insomnia group displayed lower estimated fractions of gamma-delta T cells and naïve CD4 T cells, alongside elevated proportions of resting CD4 memory T cells, resting natural killer cells, and memory B cells. Because all eight excluded samples belonged to the control cohort, an all-sample sensitivity analysis including all forty-two participants was also conducted, identifying ten significant cell fractions at adjusted q-values below 0.05. Only resting natural killer cells, naïve CD4 T cells, and resting CD4 memory T cells remained consistently significant across both inclusion criteria. In pathway-to-cell correlation testing, an association between oxidative stress and M1 macrophages attenuated from a Spearman rho of negative 0.726 in the all-sample analysis to negative 0.371 with a non-significant q-value of 0.324 under quality control filtering, demonstrating substantial sensitivity to sample inclusion.

To determine whether the identified transcriptional signatures were driven by underlying germline genetic architecture, the authors performed summary-data-based Mendelian randomization paired with the heterogeneity in dependent instruments test. By integrating eQTLGen Phase I cis-expression quantitative trait loci from 31,684 blood samples with genome-wide association study summary statistics for insomnia comprising 386,533 UK Biobank participants, the analysis evaluated potential causal relationships. Seven of the nine candidate genes were testable within this framework, while HLA-G was excluded due to linkage disequilibrium complexity across the major histocompatibility complex locus and FKBP5 was excluded following probe quality filtering. Following Bonferroni correction for seven tests at an adjusted threshold of 0.0071, none of the evaluated genes reached significance. PTGES3 yielded an unadjusted p-value of 0.100, while SPTLC1 produced a p-value of 0.266. All testable genes passed the heterogeneity test with p-values exceeding 0.05. The researchers emphasized that these findings indicate an absence of detectable cis-eQTL-mediated causal regulation under current statistical power, but do not disprove genetic contributions or prove environmental or epigenetic causality.

The translational druggability landscape of the candidate genes was examined through the Drug Gene Interaction Database version 5, revealing three distinct tiers of pharmacological development. In the first tier, FKBP5 possessed twelve documented drug interaction records, including four Food and Drug Administration-approved antidepressant compounds, specifically nefazodone, citalopram, clomipramine, and bupropion, alongside eight investigational molecules. Similarly, P2RX7 demonstrated seven interaction records involving investigational antagonists currently undergoing clinical evaluation for neuropsychiatric and inflammatory indications. In the second tier, PTGES3 showed three drug records, HLA-G possessed two records, and TNFAIP3 had one record for methotrexate. In the third tier, SPTLC1, MX1, and IRF7 had no documented drug interactions in the database. As the sole consensus hub gene identified across all three machine-learning algorithms, SPTLC1 represents a comparatively underexplored candidate target with unmapped pharmacological intervention potential.

The study authors highlighted several foundational limitations inherent to their computational design. The primary discovery dataset derived insomnia cases from the Behavioral Treatment of Insomnia in Aging trial and controls from the Sleep Health and Aging Research study, introducing potential baseline cohort differences that cannot be mathematically uncoupled from insomnia status. Furthermore, the modest overall cohort size of forty-two individuals creates high-dimensional analytical constraints that necessitate independent prospective replication using matching recruitment designs. Cellular estimates from bulk microarray deconvolution reflect relative proportions rather than absolute cell counts, and several cellular findings exhibited marked sensitivity to quality-filtering parameters. Consequently, the authors characterized their findings as exploratory and hypothesis-generating, emphasizing the necessity of targeted experimental confirmation through quantitative polymerase chain reaction, Western blotting, flow cytometry, single-cell sequencing, and functional gene perturbation models before these molecular markers can inform clinical diagnostics or therapy.

Subject of Research: Transcriptomic and immune-genomic profiling of candidate hub genes in chronic insomnia

Article Title: Integrative transcriptomic and immune-genomic analysis identifies oxidative-stress-associated immune signatures and SPTLC1, PTGES3, and HLA-G as candidate hub genes in chronic insomnia

Article References: Xin, Z. (2026). Integrative transcriptomic and immune-genomic analysis identifies oxidative-stress-associated immune signatures and SPTLC1, PTGES3, and HLA-G as candidate hub genes in chronic insomnia. Egyptian Journal of Medical Human Genetics, 27(1), Article 72. https://doi.org/10.1186/s43042-026-00903-y

Image Credits: AI Generated

DOI: 10.1186/s43042-026-00903-y

Keywords: chronic insomnia, transcriptomics, immune genomics, oxidative stress, SPTLC1, PTGES3, HLA-G, WGCNA, machine learning, CIBERSORTx, Mendelian randomization, Integrative

News Source: Juliet Wilcox. (November 7, 2026). Transcriptomic Analysis Identifies Candidate Hub Genes and Immune Signatures in Insomnia. Scienmag.

Tags: chronic insomniaCIBERSORTxHLA-Gimmune genomicsIntegrativeMachine LearningMendelian randomizationoxidative stressPTGES3SPTLC1TranscriptomicsWGCNA
Share12Tweet7Share2ShareShareShare1

Related Posts

Severe Early Infection Markers Linked to Rare Pediatric Post-Infectious Airway Obliteration

Severe Early Infection Markers Linked to Rare Pediatric Post-Infectious Airway Obliteration

November 17, 2026
Retinal Imaging Detects Deep Foveal Avascular Zone Enlargement in Early Alzheimer’s Disease

Retinal Imaging Detects Deep Foveal Avascular Zone Enlargement in Early Alzheimer’s Disease

November 17, 2026

Inhibiting EID1 Boosts Immune Cell Cooperation to Suppress Experimental Metastasis

November 17, 2026

Subjective Cognitive Decline Prediction Models Face High Bias Risk and Limited Validation

November 17, 2026

POPULAR NEWS

  • Mobile Health Units With Community Workers Address Critical Hypertension Care Gaps

    Mobile Health Units With Community Workers Address Critical Hypertension Care Gaps

    29 shares
    Share 12 Tweet 7
  • Brazilian EQ-5D Mapping Algorithm Offers Alternative to European-Based Standards

    29 shares
    Share 12 Tweet 7
  • Self-Assembled Berberine-Gallic Acid Nanorods Ameliorate Ulcerative Colitis in Mice

    29 shares
    Share 12 Tweet 7
  • Tablet Augmented Reality System May Reduce Preoperative Anxiety in Pediatric Surgical Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Severe Early Infection Markers Linked to Rare Pediatric Post-Infectious Airway Obliteration

Retinal Imaging Detects Deep Foveal Avascular Zone Enlargement in Early Alzheimer’s Disease

Review Shows Nature-Mimicking Architectures Enhance Semiconductor Photocatalyst Performance and Solar Conversion

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.